Guanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

03/18

Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.

The meeting agenda includes: 1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025. 2. Considering the declaration of a final dividend for FY2025. 3. Addressing any other business matters.

Chairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.

The announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1118495290"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118495290\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118495290?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 18:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118495290","market":"hk","top_or_hot":-1,"title":"Guanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","media":"Bulletin Express","content":"<p>Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.</p>\n<p>The meeting agenda includes:\n1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025.\n2. Considering the declaration of a final dividend for FY2025.\n3. Addressing any other business matters.</p>\n<p>Chairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>\n<p>The announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-18 18:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.</p>\n<p>The meeting agenda includes:\n1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025.\n2. Considering the declaration of a final dividend for FY2025.\n3. Addressing any other business matters.</p>\n<p>Chairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>\n<p>The announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1118495290","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118495290","pubTimestamp":1773830459,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026. The meeting agenda includes: 1. Reviewing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02427":"GUANZE MEDICAL"},"translate_title":"冠泽医疗(02427)安排2026年3月31日董事会会议批准2025财年业绩及考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.\nThe meeting agenda includes:\n1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025.\n2. Considering the declaration of a final dividend for FY2025.\n3. Addressing any other business matters.\nChairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.\nThe announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}